FIELD: medicine, dermatology, pharmacy. SUBSTANCE: invention proposes agent comprising components in the following ratio, wt.-%: doxycyclin hydrochloride, 7.0-11.0; zinc oxide, 4.0-8.0; glycerol, 9.0-12.0; "Perftoran" emulsion, the balance. EFFECT: enhanced effectiveness of agent, reduced treatment time of leprous patients. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF TROPHIC ULCER AND BURN IN LEPROSY PATIENTS | 1995 |
|
RU2095065C1 |
METHOD FOR TROPHIC ULTRA TREATMENT IN PATIENTS WITH LEPROSY | 2020 |
|
RU2753587C1 |
METHOD OF TREATMENT OF CHRONIC NEURITIDES IN PATIENTS ILL WITH LEPRA | 1996 |
|
RU2135152C1 |
AGENT FOR HEALING TROPHIC ULCER OF PATIENTS ILL WITH LEPROSY | 0 |
|
SU1196001A1 |
METHOD FOR PREDICTING LEPROUS NODULAR ERYTHEMA PROGRESS | 2000 |
|
RU2171991C1 |
METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
METHOD FOR TYPING LEPROMATOUS LEPROSY | 2009 |
|
RU2415431C1 |
METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
METHOD FOR PREDICTING EXACERBATION OF LEPROUS NEUROPATHIES IN PATIENTS AT LEPROSY | 2006 |
|
RU2310393C1 |
Authors
Dates
2003-06-10—Published
2002-05-13—Filed